Starting this week, our premium annual membership service, 23andMe+, will be available widely to consumers in the UK and Canada who are interested in exploring a little deeper into what their DNA says about their health and finding ways to research their ancestry faster and more efficiently.
Previously 23andMe+ had been available in the UK and Canada only to existing Health + Ancestry Service customers on our V5 chip. As in the US, consumers in the UK and Canada can now purchase a bundle that includes our Health + Ancestry Service with a 1-year prepaid 23andMe+ Membership.
In addition to the more than 150 reports Health + Ancestry Service customers already receive, 23andMe+ Membership offers members exclusive access to additional premium reports and features delivered throughout the year. These additional benefits give members a way to go deeper into their health.
This premium content includes Pharmacogenetics reports,* which can help you learn about how your DNA may impact the way your body processes certain medications; genetic reports Powered by 23andMe Research, which can provide insight into your likelihood of developing conditions like high blood pressure, atrial fibrillation, and migraines; as well as enhanced ancestry features including advanced filtering and access to more DNA relatives.
Find Out More
Existing Health + Ancestry Service customers on our V5 chip can join 23andMe+ Membership for an annual price of $39 in Canada or £19 in the UK.
Not yet a customer?
With more genetic reports, more health insights, and more features, we hope 23andMe+ gives individuals the choice to help them discover even more about themselves to keep fueling their health journeys. Health is in our DNA.
*The 23andMe PGS test uses qualitative genotyping to detect 6 variants in 3 genes in the genomic DNA of adults from saliva for the purpose of reporting and interpreting information about the processing of certain therapeutics to inform discussions with a healthcare professional. It does not describe if a person will or will not respond to a particular therapeutic and does not describe the association between detected variants and any specific therapeutic. Results should be confirmed in a clinical setting with independent genetic testing before taking any medical action. Warning: Test information should not be used to start, stop, or change any course of treatment and does not test for all possible variants that may affect metabolism or protein function. The PGS test is not a substitute for visits to a healthcare professional. Making changes to your current regimen can lead to harmful side effects or reduced intended benefits of your medication, therefore consult with your healthcare professional before taking any medical action. For a complete list of the 6 variants tested, visit Pharmacogenetics Important Test Information.